Cervical cancer, Version 1.2020 featured updates to the NCCN guidelines

Nadeem R. Abu-Rustum, Catheryn M. Yashar, Sarah Bean, Kristin Bradley, Susana M. Campos, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Shari Damast, Christine M. Fisher, Peter Frederick, David K. Gaffney, Robert Giuntoli, Ernest Han, Warner K. Huh, John R. Lurain, Andrea Mariani, David Mutch, Christa NagelLarissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Rachel Sisodia, Todd Tillmanns, Stefanie Ueda, Renata Urban, Emily Wyse, Nicole R. McMillian, Angela D. Motter

Research output: Contribution to journalArticlepeer-review

232 Scopus citations

Abstract

The NCCN Guidelines for Cervical Cancer provide recommendations for diagnostic workup, staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to first- and second-line systemic therapy recommendations for patients with recurrent or metastatic disease, and emerging evidence on a new histopathologic classification system for HPV-related endocervical adenocarcinoma.

Original languageEnglish
Pages (from-to)660-666
Number of pages7
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume18
Issue number6
DOIs
StatePublished - Jun 2020

Fingerprint

Dive into the research topics of 'Cervical cancer, Version 1.2020 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this